[Hormone receptor analysis and cytostatic agent sensitivity testing. Significance in additional therapy planning of breast carcinoma].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000032:analysis / Q000188:drug therapy*; D004958:Estradiol; D005260:Female; D006801:Humans; D011956:Receptors, Cell Surface / Q000032:analysis*; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D011987:Receptors, Steroid / Q000032:analysis*
D000970:Antineoplastic Agents; D011956:Receptors, Cell Surface; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D011987:Receptors, Steroid; D004958:Estradiol
Hormonrezeptoranalyse und Zytostatika-Sensitivitätstestung.